HIGHBRIDGE CAPITAL MANAGEMENT LLC

Position in RNA — Atrium Therapeutics, Inc.

CIK 919185 NEW YORK, NY

Position in RNA

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$547,982

New position

Shares Held

40,986

first reported quarter

Ownership

0.240%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

HIGHBRIDGE CAPITAL MANAGEMENT LLC holds $6,544,434 across 4 Biotechnology names. RNA ranks #3 (8.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	SRPT	Sarepta Therapeutics, Inc.	250,000	$5,440,000
2	RVPH	Reviva Pharmaceuticals Holdings, Inc.	762,236	$556,203
3	RNA	Atrium Therapeutics, Inc. This page	40,986	$547,982
4	CLDI	Calidi Biotherapeutics, Inc.	1,042	$249

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$547,982	40,986	—	Shares	Sole	2026-05-15
No filing history on record for this holder in this stock.